Kotaro Kodama

1.2k total citations
10 papers, 893 citations indexed

About

Kotaro Kodama is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kotaro Kodama has authored 10 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kotaro Kodama's work include Cancer Mechanisms and Therapy (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kotaro Kodama is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kotaro Kodama collaborates with scholars based in Japan and United States. Kotaro Kodama's co-authors include Kiyoshi Okamoto, Masao Iwata, Junji Matsui, Yasuhiro Funahashi, Takayuki Kimura, Kazuma Takase, Yukinori Minoshima, Osamu Tohyama, Akihiko Tsuruoka and Yuji Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kotaro Kodama

10 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kotaro Kodama Japan	6	371	299	232	228	193	10	893
Osamu Tohyama Japan	6	372 1.0×	223 0.7×	211 0.9×	259 1.1×	131 0.7×	11	785
Yu-Chien Chou United States	5	481 1.3×	241 0.8×	418 1.8×	445 2.0×	197 1.0×	5	1.1k
Jessica Orf United States	7	507 1.4×	243 0.8×	437 1.9×	545 2.4×	205 1.1×	9	1.3k
Bolorsukh Gansukh United States	6	261 0.7×	421 1.4×	141 0.6×	204 0.9×	164 0.8×	8	847
Judit Peix Spain	7	157 0.4×	298 1.0×	111 0.5×	307 1.3×	119 0.6×	10	657
J. Kalmus Germany	10	708 1.9×	189 0.6×	294 1.3×	117 0.5×	360 1.9×	22	1.0k
Suresh Anaganti Italy	9	395 1.1×	70 0.2×	169 0.7×	343 1.5×	132 0.7×	10	814
Toshiyuki Tamai Japan	14	323 0.9×	757 2.5×	229 1.0×	164 0.7×	352 1.8×	32	1.1k
Laia Cabellos Spain	9	235 0.6×	464 1.6×	164 0.7×	721 3.2×	201 1.0×	19	1.3k
Elena Maccaroni Italy	17	545 1.5×	125 0.4×	299 1.3×	247 1.1×	138 0.7×	54	944

Countries citing papers authored by Kotaro Kodama

Since Specialization

Citations

This map shows the geographic impact of Kotaro Kodama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kotaro Kodama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kotaro Kodama more than expected).

Fields of papers citing papers by Kotaro Kodama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kotaro Kodama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kotaro Kodama. The network helps show where Kotaro Kodama may publish in the future.

Co-authorship network of co-authors of Kotaro Kodama

This figure shows the co-authorship network connecting the top 25 collaborators of Kotaro Kodama. A scholar is included among the top collaborators of Kotaro Kodama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kotaro Kodama. Kotaro Kodama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Adachi, Yusuke, Masahiro Matsuki, Hideki Watanabe, et al.. (2019). Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma. Cancer Investigation. 37(4-5). 185–198. 14 indexed citations

Kimura, Takayuki, Yu Kato, Yoichi Ozawa, et al.. (2018). Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model. Cancer Science. 109(12). 3993–4002. 240 indexed citations

Makker, Vicky, Allen Lee Cohn, Matthew H. Taylor, et al.. (2018). Biomarker results and preclinical rationale for combination lenvatinib and pembrolizumab in advanced endometrial carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 5597–5597. 5 indexed citations

Koyama, Noriyuki, et al.. (2016). Clinical benefit of eribulin (Halaven<sup>®</sup>) in the treatment of advanced soft tissue sarcoma patients and the novel anti-tumor mechanisms. Folia Pharmacologica Japonica. 148(6). 329–333. 1 indexed citations

Narita, Yusuke, Kiyoshi Okamoto, Kazuma Takase, et al.. (2014). Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model. Molecular Cancer Therapeutics. 13(4). 823–832. 23 indexed citations

Tohyama, Osamu, Junji Matsui, Kotaro Kodama, et al.. (2014). Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models. Journal of Thyroid Research. 2014. 1–13. 362 indexed citations

Okamoto, Kiyoshi, Kotaro Kodama, Kazuma Takase, et al.. (2013). Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models. Cancer Letters. 340(1). 97–103. 237 indexed citations

Kodama, Kotaro, Hideaki Fujisaki, Hiroshi Kato, et al.. (2010). E3710, a New Proton Pump Inhibitor, with a Long-Lasting Inhibitory Effect on Gastric Acid Secretion. Journal of Pharmacology and Experimental Therapeutics. 334(2). 395–401. 9 indexed citations

Kawano, Masanori, Koji Sumii, Kotaro Kodama, et al.. (1998). Role of nitric oxide in lipopolysaccharide-induced inhibition of gastric gastrin secretion. Gastroenterology. 114. A172–A172. 1 indexed citations

10.

Tominaga, Keiko, Shigenobu Shibata, Kotaro Kodama, & Showa Ueki. (1989). Effects of anxiolytics 5-HT1A agonist on the circadian rhythm of wheel-running activity of the namster under a constant light condition. The Japanese Journal of Pharmacology. 49. 229–229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact